Pharmaceutical Care for a Patient with Multiple Pulmonary Infection after Renal Transplantation
10.6039/j.issn.1001-0408.2015.35.45
- VernacularTitle:1例肾移植术后合并多重肺部感染患者的药学监护
- Author:
Yuanchao ZHU
;
Yongfang HU
;
Liping YANG
;
Xin HU
- Publication Type:Journal Article
- Keywords:
Renal transplantation;
Multiple pulmonary infection;
Pneumocystis pneumonia;
Cytomegalovirus pneumonia;
Pharmaceutical care
- From:
China Pharmacy
2015;26(35):5022-5024
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the role of clinical pharmacists in the therapy for patient with multiple pulmonary in-fection after renal transplantation. METHODS:Clinical pharmacists participated in drug therapy for a patient with multiple pulmo-nary infection after renal transplantation,and assisted physicians to formulate primary therapy plan:ganciclovir 250 mg,ivgtt,q12 h+ Cefoperazone sodium and sulbactam sodium 3 g,ivgtt,bid+ methylprednisolone 80 mg,ivgtt,qd+ Compound sulfamethoxazole tablet,2 piece,po,qd+Ciclosporin soft capsule 75 mg,po,q12 h+Sodium bicarbonate tablet 1 g,po,qd+Nifedipine controlled release tablet 30 mg,po,qd+Famotidine tablet 20 mg,po,bid. The dose of ganciclovir was adjusted twice because of complica-tion cytomegaloviral pneumonia;the dose of ganciclovir was adjusted twice because of complication pneumocystis pneumonia. Pre-vention and disposal of ADR,patient education were also conducted. RESULTS:Physicians adopted the suggestion of clinical phar-macists;the pulmonary infection had been controlled,and the patient was discharged from hospital. CONCLUSIONS:Clinical pharmacists identify the breakthrough point to promote rational drug use,indicating the value of pharmaceutical care in the clinical treatment.
